The Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), since the experiments in rodents in the 50’s, has become a ...

In an advance for treating male infertility, researchers transplanted a patient with his own sperm-forming stem cells that ...

Wenzhou Medical University and collaborating institutions have identified a population of human neural retinal stem-like ...

A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...

Researchers sought to determine whether using HRD sources for HSCT would be effective for pediatric patients with hematologic cancers compared with UCB sources.

A novel regimen significantly reduced risk for moderate to severe chronic graft-versus-host disease for certain patients who ...

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

The following is a summary of “Improved survival in older patients with myeloid malignancies undergoing haploidentical ...

Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...

U.S. Completed OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematological Malignancies Hematological ...